Marka R. Crittenden
- Immunology top 1%
- Immunotherapy and Immune Responses 42
- Immune Cell Function and Interaction 21
- Immune cells in cancer 11
- interferon and immune responses 8
- Phagocytosis and Immune Regulation 8
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers 63
- CAR-T cell therapy research 23
- Pancreatic and Hepatic Oncology Research 10
- Otorhinolaryngology top 5%
- Cancer Research top 10%
- Co-authors
- Michael J. GoughKristina H. YoungJason R. BairdBenjamin CottamShelly BambinaDavid J. FriedmanBrendan D. CurtiPippa Newell
- Journals
- Nature Communications (1 paper)Journal of Clinical Oncology (7 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Marka R. Crittenden
103 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 103
- Immunology 2.4k
- Oncology 2.8k
- Otorhinolaryngology 123
- Pulmonary and Respiratory Medicine 583
- Cancer Research 254
Countries citing papers authored by Marka R. Crittenden
This map shows the geographic impact of Marka R. Crittenden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marka R. Crittenden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marka R. Crittenden more than expected).
Fields of papers citing papers by Marka R. Crittenden
This network shows the impact of papers produced by Marka R. Crittenden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marka R. Crittenden. The network helps show where Marka R. Crittenden may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marka R. Crittenden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 22 | |
| 3 | 2024 | 6 | |
| 4 | 2022 | 22 | |
| 5 | 2021 | 170 | |
| 6 | 2021 | 120 | |
| 7 | 2020 | 48 | |
| 8 | 2020 | 23 | |
| 9 | 2019 | 50 | |
| 10 | 2019 | 19 | |
| 11 | 2018 | 54 | |
| 12 | 2015 | 201 | |
| 13 | 2015 | 88 | |
| 14 | 2014 | 47 | |
| 15 | 2014 | 114 | |
| 16 | 2013 | 47 | |
| 17 | 2005 | 51 | |
| 18 | 2004 | 46 | |
| 19 | 1992 | 33 | |
| 20 | End results and mortality trends in cancer. II. Cancer mortality trends in the United States, 1930-1955. | 1961 | 24 |
About Marka R. Crittenden
Marka R. Crittenden is a scholar working on Immunology, Oncology and Otorhinolaryngology, having authored 106 papers that have together received 4.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (63 papers), Immunotherapy and Immune Responses (42 papers), CAR-T cell therapy research (23 papers), Immune Cell Function and Interaction (21 papers), Immune cells in cancer (11 papers), Pancreatic and Hepatic Oncology Research (10 papers), interferon and immune responses (8 papers) and Phagocytosis and Immune Regulation (8 papers). The work is most often cited by research in Immunology (2.4k citations), Oncology (2.8k citations) and Otorhinolaryngology (123 citations). Marka R. Crittenden has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Michael J. Gough, Kristina H. Young, Jason R. Baird, Benjamin Cottam, Shelly Bambina, David J. Friedman, Brendan D. Curti, Pippa Newell, Walter J. Urba and Richard G. Vile. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.